| abstract |
An object of the present invention is to provide a cytostatic agent effective for androgen-independent prostate cancer. The present invention suppresses cell proliferation, which contains, as an active ingredient, an expression inhibitor or function inhibitor of antisense RNA (CTBP1-AS) expressed in the vicinity of the androgen receptor (AR) binding site of the C-terminal binding protein (CTBP1) gene Provide the agent. |